同源康医药-B(02410)：孟晓英辞任非执行董事

Group 1 - The core point of the article is that Dr. Meng Xiaoying has resigned from her position as a non-executive director of the company, effective from August 31, 2025, to dedicate more time to other business commitments [1] Group 2 - The resignation indicates a shift in the company's board composition, which may impact its strategic direction and governance [1] - The company may need to consider appointing a new non-executive director to fill the vacancy left by Dr. Meng [1] - This change could reflect broader trends in the industry regarding board member commitments and the balancing of multiple business interests [1]